At the 66th American Society of Hematology Annual Meeting & Exposition, Kapila Viges, MD, of MPN Research Foundation, and John Mascarenhas, MD, of the Icahn School of Medicine, engage in an in-depth discussion on myelofibrosis management. They delve into the top research priorities for myelofibrosis, emphasizing areas where innovation is urgently needed.